Oaktree Specialty Lending Corp
NASDAQ:OCSL

Watchlist Manager
Oaktree Specialty Lending Corp Logo
Oaktree Specialty Lending Corp
NASDAQ:OCSL
Watchlist
Price: 11.85 USD -0.21% Market Closed
Market Cap: $1B

Oaktree Specialty Lending Corp
Investor Relations

Oaktree Specialty Lending Corporation operates in the nuanced world of finance, where nimble strategies and prudent management are paramount. Based in Los Angeles, it is a part of the Oaktree Capital Management family, which has a reputation for its disciplined investment approach. The company specializes in providing customized debt and equity financing solutions to middle-market companies across a diverse array of industries. This focus allows it to fill a crucial gap in financing that many traditional banks may overlook. By leveraging its expertise and insight, Oaktree Specialty Lending aids these businesses during pivotal growth periods, often undertaking due diligence to ensure investments are aligned with its risk management and return standards.

The financial success of Oaktree Specialty Lending comes predominantly from the interest and fees garnered from these financing activities. Its strategic approach focuses on protecting capital and generating attractive returns by carefully crafting a balance between risk and reward. By investing in senior secured loans, it works to ensure first-lien security on the borrower's assets, which provides a safety net in case of defaults. This methodical and cautious strategy is underscored by a commitment to understanding the businesses they partner with, from evaluating financial health to understanding market dynamics. The company's model remains agile, adapting investment strategies in response to market fluctuations, ensuring it navigates the volatile seas of middle-market lending with aplomb.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q1 2026
Call Date
Feb 4, 2026
AI Summary
Q1 2026

Earnings Covered Dividend: Adjusted net investment income of $36.1 million ($0.41 per share) fully covered the $0.40 per share quarterly dividend.

Portfolio Growth: New funded investments rose to $314 million, up from $220 million last quarter, growing the portfolio by about $100 million to $2.95 billion.

Nonaccruals Stable: Nonaccruals made up 3.1% of the debt portfolio at quarter end, relatively stable sequentially and down about 85 bps year-over-year.

NAV Decline: NAV per share fell to $16.30 from $16.64, mainly due to unrealized losses, with Pluralsight accounting for 38% of the mark.

Software Exposure: Software made up 23% of investments at fair value, with 94% in first lien loans; only 2 ARR-based loans in the portfolio.

Liquidity & Leverage: Liquidity stood at $576 million and net leverage increased to 1.07x from 0.97x, reflecting higher investment activity.

Market Outlook: Management is cautiously optimistic about stable to widening spreads in 2026 and expects increased middle market M&A activity.

Key Financials
Adjusted Net Investment Income
$36.1 million
Adjusted Net Investment Income per Share
$0.41
Dividend per Share
$0.40
NAV per Share
$16.30
Adjusted Total Investment Income
$74.5 million
New Funded Investments
$314 million
Portfolio Size
$2.95 billion
Net New Investments
$135 million
Nonaccruals (as % of Debt Portfolio at Fair Value)
3.1%
Weighted Average Yield on Debt Investments
9.3%
Net Leverage Ratio
1.07x
Total Debt Outstanding
$1.6 billion
Weighted Average Interest Rate on Debt Outstanding
6.1%
Unsecured Debt (as % of Total Debt)
59%
Liquidity
$576 million
PIK Income (as % of Adjusted Total Investment Income)
6.3%
JVs Aggregate ROE
12%
Median Portfolio EBITDA
$190 million
Earnings Call Recording
Other Earnings Calls

Management

Mr. Armen Panossian J.D.
CEO & Chief Investment Officer
No Bio Available
Mr. Mathew M. Pendo
President
No Bio Available
Dr. Aman Kumar M.D.
Managing Director & Co-Portfolio Manager of Life Sciences Direct Lending
No Bio Available
Mr. Raghav Khanna
Managing Director & Co-Portfolio Manager
No Bio Available
Mr. Christopher McKown
MD,CFO & Treasurer
No Bio Available
Mr. Michael Mosticchio
Investor Relations
No Bio Available
Ms. Mary Gallegly J.D.
MD,General Counsel & Secretary
No Bio Available
Ms. Ashley Pak
Chief Compliance Officer
No Bio Available
Mr. Sandeep Kumar Khorana
Managing Director of Origination
No Bio Available
Ms. Lucia S. Kim
Senior Vice President
No Bio Available

Contacts

Address
CALIFORNIA
Los Angeles
333 S Grand Ave Fl 28
Contacts
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett